INVESTOR RELATIONS
Sensile Medical is a privately owned company. Its investor relations activities are primarily directed towards its current shareholders. A regular and ongoing information policy for its shareholders has been established.
Sensile Medical’s financing is primarily coming from private sources – individuals or organisations who believe in the potential of Sensile Medical’s people and technologies . Several public fundings such as CTI fundings are also included which validates the excellence of the technology innovations of Sensile Medical.
With a lean management structure and overhead, the funds raised to date can be used mainly to move Sensile Medical’s technology and product development forward and to establish beneficial collaborations.
If you are interested in further discussions regarding a potential investment, please use the confidential E-Mail address: